Vimarsana
Biggest News Aggregation in the World

Page 21 - Major Project News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Major Project. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Major Project Today - Breaking & Trending Today

Ascentage Pharma to Present at the J.P. Morgan 40th Annual Healthcare Conference - Vimarsana News

Ascentage Pharma to Present at the J.P. Morgan 40th Annual Healthcare Conference

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

Indonesia launches major industrial estate on Borneo island - Vimarsana News

Indonesia launches major industrial estate on Borneo island

Indonesia started construction on Tuesday of a new industrial estate on Borneo island, which officials said aims to use hydropower for plants producing items including semiconductors, lithium ion batteries, solar panels and aluminium products.

Australia: Strike Energy provides an update on Project Haber - Vimarsana News

Australia: Strike Energy provides an update on Project Haber

Strike Energy has provided an update on Project Haber, Strike’s proposed 1.4 mtpa urea development based in Geraldton in Western Australia, as it continues to progress several key engineering, approval and development milestones.

ASH 2021 | Ascentage Pharma Releases Long-Term Clinical Data of Olverembatinib (HQP1351) in Oral Presentation Demonstrating Efficacy and Safety - Vimarsana News

ASH 2021 | Ascentage Pharma Releases Long-Term Clinical Data of Olverembatinib (HQP1351) in Oral Presentation Demonstrating Efficacy and Safety

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

ASH 2021 | Ascentage Pharma Presents Latest Data from Two Studies of Bcl-2-Selective Inhibitor Lisaftoclax (APG-2575), Including a China Study Demonstrating Complete Responses - Vimarsana News

ASH 2021 | Ascentage Pharma Presents Latest Data from Two Studies of Bcl-2-Selective Inhibitor Lisaftoclax (APG-2575), Including a China Study Demonstrating Complete Responses

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...